Raphael Pharmaceutical Inc. Stock-Based Compensation
Raphael Pharmaceutical Inc. (RAPH) reported Stock-Based Compensation of $245.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.00K, a 99.65% decline year-over-year.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $39.00K.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $8.00K.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $197.00K.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $245.00K, a 30.00% decline from fiscal 2024.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $350.00K, a 75.00% increase from fiscal 2023.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $200.00K, a 91.27% decline from fiscal 2022.
- Raphael Pharmaceutical Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.29M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $40.00K derived: sum of 2 quarters · filed 2026-03-31 | $48.00K derived: sum of 3 quarters · filed 2026-08-14 | $245.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $47.00K derived: sum of 2 quarters · filed 2026-08-14 | $244.00K 10-Q · filed 2025-11-13 | $533.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $205.00K 10-Q · filed 2026-08-14 | $494.00K derived: sum of 3 quarters · filed 2026-08-14 | $494.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $197.00K 10-Q · filed 2026-05-14 | $486.00K derived: sum of 2 quarters · filed 2026-05-14 | $486.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $289.00K derived: sum of 2 quarters · filed 2026-03-31 | $350.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $61.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $61.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $200.00K 10-K · filed 2024-03-28 | |||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-12 | |||
| 2022-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.00M derived: sum of 2 quarters · filed 2024-03-28 | $2.29M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.49M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $290.00K 10-Q · filed 2023-08-09 |